PHILLIP YOUSEF: Open Payments
NPI 1679052534 · GLEN OAKS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 32 payments from 7 companies in 2025. Trend: 2023 $473 · 2024 $400 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $439 |
| GENZYME CORPORATION | 9 | $187 |
| GlaxoSmithKline, LLC. | 7 | $166 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ALK-Abello, Inc | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $16 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, AYVAKIT, Rhapsido, Odactra, IMMULITE 1000 Immunoassay System, Ryaltris.
Industry payments across NY — which companies pay providers there.
